e-learning
resources
Paris 2018
Sunday, 16.09.2018
Mitochondrial dysfunction as a driver of lung disease
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Metabolic control of longevity
N. Sommer (Gießen, Germany)
Source:
International Congress 2018 – Mitochondrial dysfunction as a driver of lung disease
Session:
Mitochondrial dysfunction as a driver of lung disease
Session type:
Symposium
Number:
1630
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
N. Sommer (Gießen, Germany). Metabolic control of longevity. International Congress 2018 – Mitochondrial dysfunction as a driver of lung disease
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Diagnostic tools for Obstructive Sleep Apnoea in adults and children
Expert interview: Physiological classification of lung function impairment
Occupational exposures to respiratory diseases: A case-based discussion
Related content which might interest you:
Metabolic assessment
Source: International Congress 2014 – PG13 Assessment of the obstructive sleep apnoea patient
Year: 2014
Metabolic reprogramming in IPF
Source: ERS Research Seminar 2017 – Integrating systems biology approach in idiopathic pulmonary fibrosis research
Year: 2016
Diabetes and metabolic aspects of OSA
Source: Eur Respir Mon 2010; 50: 189-215
Year: 2010
Metabolic consequences of OSA in children
Source: Annual Congress 2009 - PG21 Morbidity and mortality of sleep-disordered breathing: jointly organised with ACCP
Year: 2009
Metabolic aspects of energy expenditure
Source: Annual Congress 2003 - Energy expenditure in COPD, basic mechanisms and interventions
Year: 2003
Asthma phenotypes: do metabolic pathways hold the key?
Source: International Congress 2017 – Metabolism in respiratory diseases: time for a rethink
Year: 2017
Defective metabolic adaptation in the pathogenesis of COPD
Source: International Congress 2019 – Metabolic alterations as a driver of chronicity in lung disease
Year: 2019
Metabolic responses to incremental exercise
Source: ERS Skills course - Clinical exercise testing: advanced
Year: 2018
Exercise physiology: the metabolic response to incremental exercise
Source: ERS Course 2017
Year: 2017
Benefits of improved air quality on ageing lungs: impacts of genetics and obesity
Source: Eur Respir J, 53 (4) 1801780; 10.1183/13993003.01780-2018
Year: 2019
Metabolic effects of OSAS and cardiovascular risk
Source: Research Seminar 2007 - Metabolic Aspects of the Obstructive Sleep Apnea Syndrome (OSAS)
Year: 2007
Metabolic changes in lung ageing and COPD
Source: International Congress 2019 – Metabolic alterations in lung ageing and disease
Year: 2019
Physiological phenotypes
Source: Eur Respir Monogr 2015; 67: 9-23
Year: 2015
Lung function, insulin resistance and metabolic syndrome in Korean males: a population-based study
Source: Annual Congress 2008 - Lung function in respiratory disease
Year: 2008
Metabolic syndrome
Source: Eur Respir Monogr 2015; 67: 221-237
Year: 2015
Impact of
diabetes mellitus
on functional capacity and cardiac autonomic control: Spectral and non linear indices analysis
Source: Annual Congress 2013 –Assessment methods involved in the physiotherapy treatment in different patient populations
Year: 2013
Effect of CPAP treatment on endothelial function, inflammatory markers, blood pressure and glucose control in male and female patients with OSAS
Source: International Congress 2014 – Sleep disordered breathing 3
Year: 2014
Metabolic consequences of obesity as an “outside in” mechanism of disease severity in asthma
Source: Eur Respir J 2016; 48: 291-293
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept